Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Signature to Predict the Persistence of Post-traumatic Headache

NCT06132529 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06132529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06132529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Signature to Predict the Persistence of Post-traumatic Headache
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
June 3, 2019
Completion date
July 31, 2025
Enrollment
151 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, post-traumatic headache